Synthesis and evaluation of N-acetyl-l-tyrosine based compounds as PPARα selective activators

Synthesis and evaluation of N-acetyl-l-tyrosine based compounds as PPARα selective activators Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARα selective activators Synthesis and biological activity of l-tyrosine-based PPARγ agonists with reduced molecular weight N-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents Design and Synthesis of α-Aryloxyphenylacetic Acid Derivatives:  A Novel Class of PPARα/γ Dual Agonists with Potent Antihyperglycemic and Lipid Modulating Activity Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia Structural development studies of PPARs ligands based on tyrosine scaffold Design, synthesis, and evaluation of 2-alkoxydihydrocinnamates as PPAR agonists Design, Synthesis, and Biological Evaluation of Novel Constrained meta-Substituted Phenyl Propanoic Acids as Peroxisome Proliferator-Activated Receptor α and γ Dual Agonists Design, synthesis, and evaluation of novel l-phenylglycine derivatives as potential PPARγ lead compounds